Hospital resource consumption in patients with diabetes and multivessel coronary disease undergoing revascularization

American Journal of Managed Care

Volumn 6, Issue 2, 2000, Pages 217-229

  Culler, Steven D ^a   Weintraub, William S ^b   Shaw, Leslee J ^b   Becker, Edmund R ^a  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INSULIN;

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG COST; FEMALE; HOSPITAL CARE; HOSPITAL COST; HOSPITAL UTILIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REIMBURSEMENT; RESOURCE ALLOCATION; REVASCULARIZATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; UTILIZATION REVIEW;

EID: 0034060516     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. American Diabetes Association: Economic consequences of diabetes mellitus in the United States in 1997. Diabetes Care 1998;21:296-309.
2. Garcia MJ, McNamara PM, Gordon T, Kannell WB. Morbidity and mortality in diabetes in the Framingham population. Sixteen-year follow-up study. Diabetes 1974;23:105-111.
3. Vigorito C, Betocchi S, Bonzani G, et al. Severity of coronary artery disease in patients with diabetes mellitus: Angiographic study of 34 diabetic and 120 non-diabetic patients. Am Heart J 1980;100:782-787.
4. Dortimer AC, Schenoy PN, Shiroff PA, et al. Diffuse coronary artery disease in diabetic patients: Fact or fiction? Circulation 1978;57:133-136.
5. Weintraub WS, Stein B, Kosinski AS, et al. Outcomes of coronary bypass surgery versus coronary angioplasty in diabetics with multivessel coronary artery disease. J Am Coll Cardiol 1998;31:10-19.
6. Barsness GW, Peterson ED, Ohman EM, et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 1997;96:2551-2556.
7. King SB III, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994;331:1044-1050.
8. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 1996;335:217-225.
9. CABRI Trial Participants: First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation). Lancet 1995;346:1179-1184.
10. Taylor GJ, Mikell FL, Moses HW, et al. Determinants of hospital charges for coronary artery bypass surgery: The economic consequences of postoperative complications. Am J Cardiol 1990;65:309-313.
11. Mauldin PD, Weintraub WS, Becker ER. Predicting hospital costs for first-time coronary artery bypass grafting from pre-operative and postoperative variables. Am J Cardiol 1994;74:772-775.
12. Smith LR, Milano CA, Molter BS, Elbeery JR, Sabiston DC, Smith PK. Preoperative determinants of postoperative costs associated with coronary artery bypass graft surgery. Circulation 1994;90(pt.II):124-128.
13. Hlatky MA, Lipscomb J, Nelson C, et al. Resource use and cost of initial coronary revascularization: Coronary angioplasty versus coronary bypass surgery. Circulation 1990;(suppl 5):IV-203-IV-213.
14. Weintraub WS, Mauldin PD, Becker ER, Kosinski AS, King SB III. A comparison of the cost and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease: Results from the Emory Angioplasty versus Surgery Trial (EAST). Circulation 1995;92:2831-2840.
15. Hlatky MA, Rogers WJ, Johnstone I, et al. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med 1997;336:92-99.
16. Stein B, Weintraub WS, Gebhart SSP, et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation 1995;91:979-989.
17. Salomon NW, Page US, Okies EJ, Stephens J, Krause AH, Bigelow JC. Diabetes mellitus and coronary artery bypass. J Thorac Cardiovasc Surg 1983; 85:264-271.
18. Douglas JS, King SB III, Roubin GS. Technique of percutaneous transluminal angioplasty of the coronary, renal, mesenteric, and peripheral arteries. In: Hurst JW, Schlant RC, Rackley CE, Sonnenblick EH, Wenger NK, eds. The Heart. 7th ed. New York, NY: McGraw-Hill Book Co;1999:2131-2156.
19. Jones EL, Craver JM, King SB III, et al. Clinical, anatomic and functional descriptors influencing morbidity, survival and adequacy of revascularization following coronary bypass. Ann Surg 1980;192:390-402.
20. Finkler SA. The distinction between cost and charges. Ann Intern Med 1982;96:102-109.
21. US Department of Labor, Bureau of Labor Statistics. CPI Detailed Report, 1986-1996.
22. SAS Institute, Inc. SAS User's Guide, Version 6. 4th ed. Cary, NC: SAS Institute Inc;1995.
23. Mark DB, Tally JD, Topol EJ, et al. Economic assessment of platelet glycoprotein IIb/IIIa inhibition for prevention of ischemic complications of high-risk coronary angioplasty. EPIC Investigators. Circulation 1996;94:629-635.
24. St Claire DA, King SB III. Effect of diabetes mellitus on outcomes after percutaneous transluminal coronary angioplasty. J Cardiovasc Risk 1997;4:112-120.
25. Kuntz RE. Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: The diabetes-percutaneous transluminal coronary angioplasty dilemma. Circulation 1999;99:847-851.
26. Hall RE, Ash AS, Ghali WA, Moskowitz MA. Hospital cost of complications associated with coronary artery bypass graft surgery. Am J Cardiol 1997;79:1680-1682.